Keywords: A2Ms; α-2- macroglobulins; AFLEI; elastase inhibitor from Aspergillus flavus; AFUEI; elastase inhibitor from Aspergillus fumigatus; AP; α-2-antiplasmin; AT; antithrombin; bFGF; basic fibroblast growth factor; BSuPI; Bacillus subtilis protease inhibitor;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ALS; amyotrophic lateral sclerosis; ALT; alternative telomere lengthening mechanisms; ARIC; Atherosclerosis risk in communities; BP; blood pressure; CAD; coronary artery disease; CML; chronic myelogenous leukemia; CVD; cardiovascular disease; EC; endothel
Keywords: African trypanosomiasis; Trypanosoma brucei; Antitrypanosomal activity; NNRTIs; Triazines;
Design, synthesis and biological evaluation of substituted (+)-SG-1 derivatives as novel anti-HIV agents
Keywords: HIV; NNRTIs; SG-1; Structure-activity relationship; NNRTI-resistant;
The discovery of novel diarylpyri(mi)dine derivatives with high level activity against a wide variety of HIV-1 strains as well as against HIV-2
Keywords: HIV-1; HIV-2; NNRTIs; DAPY; Drug design; Entrance channel;
Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus
Keywords: HIV-1; NNRTIs; Triazole; Diarylnicotinamide; Entrance channel; Drug design;
Oxygen binding isotope effects of triazole-based HIV-1 reverse transcriptase inhibitors indicate the actual binding site
Keywords: HIV-1 reverse transcriptase; Binding isotope effects; QM/MM; FEP; Free energy of binding; Interaction energy; Potential energy; NNRTIs; HAART; Triazole-based RTIs;
Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives as potent HIV-1 NNRTIs
Keywords: HIV-1; NNRTIs; Pyridine; Bioisosteric principle; Drug design;
Discovery of novel piperidine-substituted indolylarylsulfones as potent HIV NNRTIs via structure-guided scaffold morphing and fragment rearrangement
Keywords: HIV; NNRTIs; Indolylarylsulfones; Antiviral activity; SAR; Molecular modeling; Chemical space; Drug design;
Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003-2015: Transmitted drug resistance is due to onward transmissions
Keywords: cART; combination antiretroviral therapy; COMET; COntext-based modeling for expeditious typing; CPR; calibrated population resistance; CRFs; circulating recombinant forms; GTR; general time-reversible; HCDCP; Hellenic Center for Disease Control and Preven
Discovery of uracil-bearing DAPYs derivatives as novel HIV-1 NNRTIs via crystallographic overlay-based molecular hybridization
Keywords: NNRTIs; DAPYs; Uracil; Molecular hybridization; Physicochemical properties; Drug design;
Arylazolyl(azinyl)thioacetanilides. Part 20: Discovery of novel purinylthioacetanilides derivatives as potent HIV-1 NNRTIs via a structure-based bioisosterism approach
Keywords: HIV-1; AIDS; NNRTIs; Purinylthioacetanilide; Anti-HIV activity; Drug design; Bioisosterism
1,6-Bis[(benzyloxy)methyl]uracil derivatives—Novel antivirals with activity against HIV-1 and influenza H1N1 virus
Keywords: Uracil; Non-nucleoside reverse transcriptase inhibitors; NNRTIs; HIV; Influenza virus
Novel (2,6-difluorophenyl)(2-(phenylamino)pyrimidin-4-yl)methanones with restricted conformation as potent non-nucleoside reverse transcriptase inhibitors against HIV-1
Keywords: Diarylpyrimidine (DAPY); Etravirine; Human immunodeficiency virus (HIV); Non-nucleoside reverse transcriptase inhibitors; NNRTIs; Rilpivirine
Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket
Keywords: HIV-1; NNRTIs; DAPY; Molecular hybridization; Drug design; Entrance channel
Computer-aided discovery of anti-HIV agents
Keywords: Structure-based design; Free energy perturbation; Anti-HIV drugs; NNRTIs;
Efavirenz a nonnucleoside reverse transcriptase inhibitor of first-generation: Approaches based on its medicinal chemistry
Keywords: AIDS; Efavirenz; Reverse transcriptase; Structure-activity relationship; Synthesis; HIV; NNRTIs;
Untangling the Gordian knot of HIV, stress, and cognitive impairment
Keywords: HIV; Stress; Inflammation; CD4; Cognition; IL-1β; Interleukin-1β; IL-2; Interleukin-2; IL-6; Interleukin-6; IL-12; Interleukin-12; IL-18; Interleukin-18; ACTH; Adrenocorticotropic hormone; AIDS; Acquired immune deficiency syndrome; ANI; Asymptomatic neu
Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 4: Design, synthesis and biological evaluation of novel imidazo[1,2-a]pyrazines
Keywords: HIV-1 RT; Imidazo[1,2-a]pyrazines; Core-refining; NNRTIs; Biological activity; Molecular simulation
Synthesis and biological evaluation of DAPY–DPEs hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase
Keywords: NNRTIs; DAPYs; DPEs; Molecular hybridization; Hybrids
Synthesis and biological evaluation of pyridinone analogues as novel potent HIV-1 NNRTIs
Keywords: HIV; human immunodeficiency virus; NNRTIs; non-nucleoside reverse transcriptase inhibitors; SARs; structure and activity relationships; HAART; highly active antiretroviral therapy; RT; reverse transcriptase; NVP; nevirapine; DLV; delavirdine; EFV; efavire
Scaffold hopping: Exploration of acetanilide-containing uracil analogues as potential NNRTIs
Keywords: Nonnucleoside reverse transcriptase; Inhibitors; NNRTIs; HIV; Uracil; Amide;
Discovery of potent HIV-1 non-nucleoside reverse transcriptase inhibitors from arylthioacetanilide structural motif
Keywords: HIV-1; NNRTIs; Arylthioacetanilides; SARs; Drug design; Drug-resistance;
Leptin in congenital and HIV-associated lipodystrophy
Keywords: POMC; pro-opiomelanocortin; NPY; neuropeptide Y; MRI; magnetic resonance imaging; AMPK; adenosine monophosphate-activated protein kinase; HIV; Human Immunodeficiency Virus; HALS; HIV-associated lipodystrophy syndrome; CT; computed tomography; DEXA; dual-e
Identification of anti-HIV agents with a novel benzo[4,5]isothiazolo[2,3-a]pyrimidine scaffold
Keywords: CCR5; CC chemokine receptor type 5; CXCR4; CXC chemokine receptor type 4; MAGI; multinuclear activation of a galactosidase indicator; NNRTIs; non-nucleoside reverse transcriptase inhibitors; NRTIs; nucleoside reverse transcriptase inhibitors; PIs; proteas
Novel indole based NNRTIs with improved potency against wild type and resistant HIV
Keywords: HIV; NNRTIs; AIDS; Indole
Physicochemical property-driven optimization of diarylaniline compounds as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
Keywords: Anti-HIV agents; Diarylaniline; NNRTIs; Physicochemical property;
Development of a cost-effective assay for genotyping of HIV-1 non-B subtype for drug resistance
Keywords: HAART; Highly Active Antiretroviral Therapy; NRTIs; Nucleoside/Nucleotide Reverse Transcriptase Inhibitors; NNRTIs; Non-Nucleoside Reverse Transcriptase Inhibitors; Genotype; Drug resistance; HIV-1;
Structural modifications of CH(OH)-DAPYs as new HIV-1 non-nucleoside reverse transcriptase inhibitors
Keywords: HIV-1; NNRTIs; Diarylpyrimidine; SAR; Antiviral activity
Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors
Keywords: HIV-1; NNRTIs; Diarylpyrimidine; SAR; Antiviral activity
Discovery of nitropyridine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors via a structure-based core refining approach
Keywords: HIV-1; Reverse transcriptase; NNRTIs; Drug design; Organic synthesis; Pyridine; Bioactivity
Arylazolyl(azinyl)thioacetanilides. Part 16: Structure-based bioisosterism design, synthesis and biological evaluation of novel pyrimidinylthioacetanilides as potent HIV-1 inhibitors
Keywords: HIV; NNRTIs; Pyrimidine; Antiviral activity; Drug design; SAR; SCR; Molecular modeling;
Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: Design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives
Keywords: BSZRGJKRHYXHIP-UHFFFAOYSA-N; JLTOSZWUKFGEJV-UHFFFAOYSA-N; WVZNAGYRPXFMRY-UHFFFAOYSA-N; ULRBWXYDRJNLNG-UHFFFAOYSA-N; YXLLVZNNNCCREE-UHFFFAOYSA-N; FYEKUVZLJJCIGP-UHFFFAOYSA-N; IYCQWQGKUDDQGF-UHFFFAOYSA-N; RZMXRCFAAJREMJ-UHFFFAOYSA-N; GYBQBADMBRADDS-UHFFFAOY
Design and synthesis of N1-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors
Keywords: HIV-1 reverse transcriptase; NNRTIs; N1-Aryl-benzimidazoles 2-substituted; Synthesis
Discovery of 2-pyridone derivatives as potent HIV-1 NNRTIs using molecular hybridization based on crystallographic overlays
Keywords: NNRTIs; HIV; Drug design; 2-Pyridone; Molecular hybridization; Docking
Design, synthesis and preliminary SAR studies of novel N-arylmethyl substituted piperidine-linked aniline derivatives as potent HIV-1 NNRTIs
Keywords: HIV-1; AIDS; NNRTIs; Synthesis; Anti-HIV-1 activity;
Design, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridization
Keywords: HIV-1; NNRTIs; DANAs; Entrance channel; Molecular hybridization; Drug design;
Rational design and synthesis of novel thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors
Keywords: Thiazolidin-4-ones; Anti-HIV-1 activity; HIV-1 reverse transcriptase; NNRTIs
Towards new C6-rigid S-DABO HIV-1 reverse transcriptase inhibitors: Synthesis, biological investigation and molecular modeling studies
Keywords: HIV-1 reverse transcriptase; NNRTIs; S-DABO; SAR; Rigid conformation;
Design, synthesis and biological evaluation of N2,N4-disubstituted-1,1,3-trioxo-2H,4H-pyrrolo[1,2-b][1,2,4,6]thiatriazine derivatives as HIV-1 NNRTIs
Keywords: HIV; Reverse transcriptase; NNRTIs; Thienothiadiazine; Pyrrolothiatriazine; Heterocycle; Drug design;
Synthesis and evaluation of novel 3-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents
Keywords: Anti-HIV-1 agents; NNRTIs; Uracil analogs; Molecular modeling analysis; HIV-1 RT;
Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs
Keywords: HIV-1; AIDS; NNRTIs; Pyridazine derivatives; Anti-HIV-1 activity;
Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIs
Keywords: Pyrimidine; Anti-HIV activity; NNRTIs; HIV-1; Reverse transcriptase;
Bifunctional inhibition of HIV-1 reverse transcriptase: A first step in designing a bifunctional triphosphate
Keywords: HIV-1; human immunodeficiency virus type 1; RT; reverse transcriptase; NRTIs; nucleoside RT inhibitors; NNRTIs; nonnucleoside RT inhibitors; dNTP; deoxynucleoside triphosphate; dNMP; 3â²-deoxynucleoside monophosphate; PPi; pyrophosphate; AZT; β-d-(+)-3â
Selection and characterization of viruses resistant to the dual acting pyrimidinedione entry and non-nucleoside reverse transcriptase inhibitor IQP-0410
Keywords: HIV; Resistance; Pyrimidinediones; NNRTIs;
Optimization of benzyloxazoles as non-nucleoside inhibitors of HIV-1 reverse transcriptase to enhance Y181C potency
Keywords: Anti-HIV agents; Computer-aided drug design; NNRTIs; Free-energy calculations
N1,N3-disubstituted uracils as nonnucleoside inhibitors of HIV-1 reverse transcriptase
Keywords: Nonnucleoside reverse transcriptase inhibitors; NNRTIs; HIV; Uracil; Benzophenone; Cinnamyl
Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors
Keywords: HIV-1; NNRTIs; Diarylpyrimidine; Benzophenone; Molecular hybridization; Antiviral activityNNRTIs, non-nucleoside reverse transcriptase inhibitors; DAPYs, diarylpyrimidine derivatives; BPs, benzophenone derivatives; NVP, nevirapine; DLV, delavirdine; HIV-1
Optimization of 2,4-diarylanilines as non-nucleoside HIV-1 reverse transcriptase inhibitors
Keywords: Diarylaniline; NNRTIs; Lead optimization; Anti-HIV agents
Synthesis, evaluation and structure-activity relationships of triazine dimers as novel antiviral agents
Keywords: HIV-1 reverse transcriptase; NNRTIs; Anti-HIV-1 activity; Triazines; Triazine dimers;